It has been suggested that SARS-CoV-2 can directly infect liver progenitor cells, cholangiocytes, and hepatocytes, partially mediated by the presence of angiotensin-converting enzyme 2 expression, which may lead to cholestasis and hepatic dysfunction (5, 74). This evidence concerns the gene ACE2 and cholestasis.